Global Drugs of Abuse Testing Market: Snapshot

According to the United Nations Office on Drugs and Crime, nearly five percent of the global adult population consumed some sort of prohibited drug at least once in 2015. That percentage escalates steeply if we consider it within the U.S., a country that has been marred by the cases of substance abuse for several decades. Similar incrementing numbers are being observed in European nations too and as a result, resilient measures are now being undertaken by respective governments to overcome this cause of premature death among the adults. Consequently, the global drugs of abuse testing market is flourishing, with the demand projected to expand at a notable CAGR of 5.4% during the forecast period of 2017 to 2025. The analysts of the report have evaluated that there were opportunities worth US$4,443.9 mn in the global drugs of abuse testing market in 2017. By the end of the aforementioned forecast period, 2025, the valuation of the market is estimated to swell up to US$6,781.6 mn.

The market for drugs of abuse testing, which can be an in-house or onsite examination of drugs within a human body, is gaining traction from a number of factors such as advancements in technology of analyzers, increasing availability of forbidden drugs, and growing emphasis on work place screening among the urban populations. The advent of testing devices that are overcoming the need for a sample of saliva, urine, or blood to be taken to a laboratory is foreseen as a major boon for the drugs of abuse testing market. On the other hand, lack of awareness regarding the availability of advanced drug testing devices and its consideration as a violation of privacy rights in some countries are a few restraints hampering the growth of the market.

global drugs of abuse testing market

Consumables Provide for the Major Chunk of Overall Demand

On the basis of product type, the drugs of abuse testing market has been segmented into three major sub segments of analyzers, rapid testing devices, and consumables. Between these segments, consumables accounted for around 35.7% market share (in terms of revenue), in 2016. One of the most common and beneficial uses of consumables is that it is used in every application for taking the sample. The segment of consumables includes fluid collection devices and rest all other reagents used in carrying out the laboratory test. The rapid testing devices are most convenient devices for carrying out the preliminary test for detection of drug in the human body owing to its portability. The test conducted using rapid testing devices usually denoted positive or negative results. If further detailed investigation is required then the testing are done in the laboratories using the analyzers.

Based on the sample type, the drugs of abuse testing market has been classified into saliva, blood, sweat, hair, and urine and breath. The urine sample type segment accounted for the major share of 39.1% of the global drugs of abuse testing market in 2016, followed by saliva. Based on testing type the market for drugs of abuse is bifurcated into pain management testing, criminal justice testing, and work place screening. The criminal justice testing segment accounted for 39.6% share of the total demand in 2016.  Based on the end user, the drugs of abuse testing market has been further categorized into hospitals, diagnostic laboratories, on the spot testing, and forensic laboratories.

The U.S. to Sustain North America as the Most Lucrative Region

Geographically, the global drugs of abuse testing market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America accounted for a 49.3% of the total demand in 2016, followed by Europe. Demand for rapid testing devices in North America is high as the government is regularizing the rules and regulation for illicit drugs consumption. By the end of 2025, the North America drugs of abuse testing market is estimated to be worth US$3,467.2 mn, expanding at an above-average CAGR of 5.8% during the forecast period of 2017 to 2025.

Thermo Fisher Scientific Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Danaher Corporation (Beckman Coulter, Inc.), and Abbott Laboratories are some of the key players that have been profiled in this report.

Global Drugs of Abuse Testing Market: Overview

This report on abuse of drug testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing drug products for abuse of drug testing as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global abuse of drug testing market with respect to the leading market segments based on product type, sample type, end-user and geographies. 

Global Drugs of Abuse Testing Market: Segmentations

Based on product type, the global drugs of abuse testing market has been segmented three major sub segments namely, analyzers, rapid testing devices and consumables. The analyzers product type segment is further sub – segmented into immunoassay analyzers, chromatographic devices and breath analyzers. The rapid testing devices product type segment is further sub segmented into urine testing devices and oral fluid testing devices. The consumables product type segment is further sub – segmented into fluid collection devices and others. The market has been further studied from the point of view of sample type. Based on sample type, the market has been segmented into saliva, breath, urine, blood, hair & sweat. On the basis of testing type, the market has been segmented into pain management testing, criminal justice testing and work place screening. Based on the end users the market is categorized into hospitals, diagnostics laboratories, on-the-spot testing and forensic laboratories.

Each of the market segments have been extensively analyzed based on the market related factors such as increase in use of illicit drugs and available testing options. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Drugs of Abuse Testing Market: Key Research Aspects

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the abuse of drug testing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global abuse of drug testing market.

Global Drugs of Abuse Testing Market: Regional Analysis

Geographically, abuse of drug testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global abuse of drug testing market.

Global Drugs of Abuse Testing Market: Competitive Landscape

Major players operating in the global drugs of abuse testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Siemens Healthineers, Abbott Laboratories and Danaher Corporation (Beckman Coulter, Inc.) exhibit the largest geographical outreach with presence in multiple drugs of abuse testing products.

The global drugs of abuse testing market is segmented as follows:

Global Drugs of Abuse Testing Market Revenue, by Product Type

  • Analyzers
    • Immunoassays Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
    • Fluid Collection Devices
    • Others

Global Drugs of Abuse Testing Market Revenue, by Sample Type

  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

Global Drugs of Abuse Testing Market Revenue, by Testing Type

  • Pain Management Testing
  • Criminal Justice Testing
  • Work Place Screening

Global Drugs of Abuse Testing Market Revenue, by End User

  • Hospitals
  • Diagnostics Laboratories
  • On-the-spot Testing
  • Forensic Laboratories

Global Drugs of Abuse Testing Market Revenue, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
.